Entry |
|
Name |
Naveglitazar (USAN/INN) |
Formula |
C25H26O6
|
Exact mass |
422.1729
|
Mol weight |
422.4703
|
Structure |
|
Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
|
Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) alpha agonist |
Comment |
Treatment of Type II diabetes and associated cardiovascular indications
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
D08949 Naveglitazar
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C1 (PPARA)
D08949 Naveglitazar (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 31
1 C8x C 21.8400 -20.1600
2 C8y C 21.8400 -21.5600
3 C8x C 23.0524 -22.2600
4 C8x C 24.2649 -21.5600
5 C8y C 24.2649 -20.1600
6 C8x C 23.0524 -19.4600
7 O2a O 20.6276 -22.2600
8 C1b C 19.4321 -21.5696
9 C1b C 18.2447 -22.2551
10 C1b C 17.0535 -21.5671
11 O2a O 15.8640 -22.2538
12 C8y C 14.6739 -21.5665
13 C1b C 25.4960 -19.4490
14 C1c C 26.7012 -20.1447
15 C6a C 27.8835 -19.4619
16 O6a O 29.0775 -20.1512
17 O6a O 27.8835 -18.0602
18 O2a O 26.7016 -21.5596
19 C1a C 27.8905 -22.2459
20 C8x C 14.6739 -20.1602
21 C8x C 13.4615 -19.4602
22 C8y C 12.2491 -20.1601
23 C8x C 12.2490 -21.5663
24 C8x C 13.4614 -22.2664
25 O2a O 11.0373 -19.4604
26 C8y C 9.8422 -20.1505
27 C8x C 8.6547 -19.4649
28 C8x C 7.4423 -20.1649
29 C8x C 7.4422 -21.5649
30 C8x C 8.6297 -22.2505
31 C8x C 9.8421 -21.5505
BOND 33
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 5 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 15 17 2
18 14 18 1 #Up
19 18 19 1
20 12 20 2
21 20 21 1
22 21 22 2
23 22 23 1
24 23 24 2
25 12 24 1
26 22 25 1
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 29 30 1
32 30 31 2
33 26 31 1
|